Literature DB >> 3360804

Human laminin B2 chain. Comparison of the complete amino acid sequence with the B1 chain reveals variability in sequence homology between different structural domains.

T Pikkarainen1, T Kallunki, K Tryggvason.   

Abstract

The complete amino acid sequence of the human laminin B2 chain has been determined by sequencing of cDNA clones. The six overlapping clones studied cover approximately 7.5 kilobases of which 5312 nucleotides were sequenced from the 5' end. The open reading frame codes for a 33-residue signal peptide and a 1576-residue B2 chain proper, which is 189 residues less than in the highly homologous B1 chain (Pikkarainen, T., Eddy, R., Fukushima, Y., Byers, M., Shows, T., Pihlajaniemi, T., Saraste, M., and Tryggvason, K. (1987) J. Biol. Chem. 262, 10454-10462). Computer analysis revealed that the B2 chain consists of distinct domains that contain helical structures, cysteine-rich repeats, and globular regions, as does the B1 chain. However, domain alpha and domain beta of the B1 chain have no counterpart in B2, and the number of cysteine-rich repeats is 12, or 1 less than in the B1 chain. The degree of homology between the two chains is highest in the cysteine repeat-containing domains III and V where 40% of the residues match. However, results demonstrate that the B1 and B2 chains of laminin are highly homologous proteins that are probably the products of related genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Three heterotrimeric laminins produced by human keratinocytes.

Authors:  C Kumagai; M Okano; Y Kitagawa
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

2.  Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.

Authors:  K Ehrig; I Leivo; W S Argraves; E Ruoslahti; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  MultiCoil: a program for predicting two- and three-stranded coiled coils.

Authors:  E Wolf; P S Kim; B Berger
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

4.  A Pst I polymorphism in the human laminin B2 chain gene on 1q25-q31.

Authors:  T Kallunki; T Pikkarainen; K Tryggvason; E R Savolainen
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

5.  Identification of the B1 and B2 subunits of human placental laminin and rat parietal-yolk-sac laminin using antisera specific for murine laminin-beta-galactosidase fusion proteins.

Authors:  J C Brown; J H Spragg; G N Wheeler; P W Taylor
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

6.  Site-directed mutagenesis and structural interpretation of the nidogen binding site of the laminin gamma1 chain.

Authors:  E Pöschl; U Mayer; J Stetefeld; R Baumgartner; T A Holak; R Huber; R Timpl
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 7.  Role of laminin-nidogen complexes in basement membrane formation during embryonic development.

Authors:  M Dziadek
Journal:  Experientia       Date:  1995-09-29

8.  Expression of laminin, type IV procollagen and 230 kDa bullous pemphigoid antigen genes by keratinocytes and fibroblasts in culture: application of the polymerase chain reaction for detection of small amounts of messenger RNA.

Authors:  K Nomura; T Sugawara; T Sato; D Sawamura; I Hashimoto; Y Sugita; J Uitto
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

9.  Human nidogen: cDNA cloning, cellular expression, and mapping of the gene to chromosome Iq43.

Authors:  D R Olsen; T Nagayoshi; M Fazio; M G Mattei; E Passage; D Weil; R Timpl; M L Chu; J Uitto
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

10.  The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.

Authors:  C Pyke; J Rømer; P Kallunki; L R Lund; E Ralfkiaer; K Danø; K Tryggvason
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.